Mallinckrodt to buy Questcor for lucrative MS drug-Reuters

Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its multiple sclerosis drug, Acthar Gel, which is set to hit sales of $1 billion this year, Reuters reported.

DealsNorth AmericaUSBriefs